T226-1374 Screening compound: N-[(3-ethoxy-4-methoxyphenyl)methyl]-5-ethyl-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

T226-1374 Screening compound: N-[(3-ethoxy-4-methoxyphenyl)methyl]-5-ethyl-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide
T226-1374 Screening compound: N-[(3-ethoxy-4-methoxyphenyl)methyl]-5-ethyl-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T226-1374
N-[(3-ethoxy-4-methoxyphenyl)methyl]-5-ethyl-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T226-1374

Molecular Formula

C23H24N4O4 (C23 H24 N4 O4)

Compound Name

N-[(3-ethoxy-4-methoxyphenyl)methyl]-5-ethyl-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

IUPAC name

N-[(3-ethoxy-4-methoxyphenyl)methyl]-5-ethyl-4-oxo-4H5H-pyrazolo[15-a]quinoxaline-7-carboxamide

SMILES

CCN(c(cc(cc1)C(NCc(cc2)cc(OCC)c2OC)=O)c1-n1nccc11)C1=O

InChI

InChI=1S/C23H24N4O4/c1-4-26-19-13-16(7-8-17(19)27-18(23(26)29)10-11-25-27)22(28)24-14-15-6-9-20(30-3)21(12-15)31-5-2/h6-13H,4-5,14H2,1-3H3,(H,24,28)

InChI Key

MNRGMKGHVYZMFQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29025665

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.015

Distribution Coefficient, logD

2.015

Water Solubility, LogSw

-2.68

Polar Surface Area

67.089

Acid Dissociation Constant (pKa)

13.68

Base Dissociation Constant (pKb)

-0.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

T226-1374 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with T226-1374 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T226-1374?
Check Price and Availability of T226-1374, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T226-1374 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T226-1374
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T226-1374
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T226-1374 available by request